Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Rangering i aksjer #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Aksjekurs
$62.83
Markedsverdi
$93.23B
Endring (1 dag)
-9.17%
Endring (1 år)
-31.36%
Land
US
Handel Boston Scientific Corporation (BSX)

Kategori

Antall utestående aksjer for Boston Scientific Corporation (BSX)
Antall utestående aksjer per December 2025: 1.48B
Ifølge Boston Scientific Corporation sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 1.48B. Ved slutten av December 2024 hadde selskapet 1.47B utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Boston Scientific Corporation (BSX) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 1.48B 0.16%
2025 1.48B 0.60%
2024 1.47B 1.27%
2023 1.45B 1.57%
2022 1.43B 0.58%
2021 1.42B 0.40%
2020 1.42B 1.81%
2019 1.39B 0.76%
2018 1.38B 0.80%
2017 1.37B 0.92%
2016 1.36B 2.25%
2015 1.33B 0.26%
2014 1.32B -1.26%
2013 1.34B -4.66%
2012 1.41B -6.80%
2011 1.51B -0.56%
2010 1.52B 0.66%
2009 1.51B 0.63%
2008 1.50B 0.78%
2007 1.49B 16.74%
2006 1.27B 54.14%
2005 826.32M -1.18%
2004 836.22M 0.98%
2003 828.07M 2.12%
2002 810.87M -2.40%
2001 830.77M 2.45%
2000 810.87M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
1.75B 17.83%
US
382.50M -74.20%
US
1.28B -13.50%
IE
1.28B -13.53%
IE
2.23B 50.64%
DE